Compass Therapeutics (CMPX) Tax Provisions (2019 - 2021)

Compass Therapeutics' Tax Provisions history runs 3 years deep, the most recent figure standing at -$13000.0 for Q4 2021.

• In Q4 2021, Tax Provisions changed N/A year-over-year to -$13000.0; the TTM figure through Sep 2022 stood at -$13000.0 (down 181.25% YoY), while the FY2020 annual figure was $32000.0, down 64.84% from the prior year.
• Tax Provisions came in at -$13000.0 for Q4 2021 at Compass Therapeutics, down from $16000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $26000.0 in Q2 2019 to a low of -$13000.0 in Q4 2021.
• A 3-year average of $14200.0 and a median of $16000.0 in 2020 frame the typical range for Tax Provisions.
• On a YoY basis, Tax Provisions climbed as much as 38.46% in 2020 and fell as far as 38.46% in 2020.
• Compass Therapeutics' Tax Provisions stood at $26000.0 in 2019, then sank by 38.46% to $16000.0 in 2020, then sank by 181.25% to -$13000.0 in 2021.
• According to Business Quant data, Tax Provisions over the past three periods registered -$13000.0, $16000.0, and $16000.0 for Q4 2021, Q2 2020, and Q1 2020 respectively.

Peer Comparison